Anecdotally, we know physicians are seeing fewer patients since COVID-19, but the magnitude of that decline is surprisingly large. In recent research conducted by Ipsos Healthcare team on the impact of COVID-19 on HCP practices, co-sponsored by M360 Research, physicians tell us their typical weOriginal Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.